Luminescent Iridium Complex-Peptide Hybrids (IPHs) for Therapeutics of Cancer: Design and Synthesis of IPHs for Detection of Cancer Cells and Induction of Their Necrosis-Type Cell Death

Table 2

Complexation constants of IPHs (assuming 1 : 1 complexation).

Analyte	Kapp (M^−1)	Kd
TRAIL	(2.3 ± 0.05) × 10^8	4.3 ± 0.1 nm
5	(3.8 ± 0.1) × 10^5	2.7 ± 0.1 μM
6	(4.0 ± 0.2)10^5	2.5 ± 0.1 μM
9	<10^4	>100 μM
2c	<10^4	>100 μM